Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-059991
Filing Date
2014-09-26
Accepted
2014-09-26 17:02:43
Documents
2
Period of Report
2014-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3951
2 EX-24 DOCUMENT attachment1.htm EX-24 4204
  Complete submission text file 0001209191-14-059991.txt   9675
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Issuer) CIK: 0001157602 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36617 | Film No.: 141124594